Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

The Role of Emicizumab in Patients with Acquired Hemophilia A

Malcolm Su, Sean Yates, Melissa Sanchez, Yu-Min Shen

Blood (2024) 144 (Supplement 1): 5505.

https://doi.org/10.1182/blood-2024-208413

Published: 2024

Journal Articles

Experiences with Emicizumab: A Retrospective Review of Patients on Emicizumab Therapy at the North Texas Hemophilia Treatment Center

Harsh Vardhan Upreti, Ganesh Raman, Yu-Min Shen

Blood (2024) 144 (Supplement 1): 5487.

https://doi.org/10.1182/blood-2024-211414

Published: 2024

Journal Articles

Stable Therapeutic Transgenic FIX Levels for More Than 10 Years in Subjects with Severe Hemophilia B Who Received scAAV2/8-LP1-Hfixco Adeno-Associated Virus Gene Therapy

Blood (2023) 142 (Supplement 1): 1056.

https://doi.org/10.1182/blood-2023-186891

Published: 2023

Journal Articles

Bortezomib in Relapsed/Refractory Autoimmune-Mediated Thrombotic Thrombocytopenic Purpura: A Single-Center Case Series and Systematic Review

Nicholas C.J. Lee, Sean Yates, Siayareh Rambally, Ravindra Sarode, Ibrahim F. Ibrahim, Yu-Min Shen, Sandra L. Hofmann, Natalie Bavli

Blood (2022) 140 (Supplement 1): 2693–2694.

https://doi.org/10.1182/blood-2022-165329

Published: 2022

Journal Articles

Surveillance of Monoclonal Gammopathy of Undetermined Significance: A Proposed Change

Hollie Elise Sheffield, Yu-Min Shen, Nivan Chowattukunnel, Waqas Haque

Blood (2021) 138 (Supplement 1): 1906.

https://doi.org/10.1182/blood-2021-144885

Published: 2021

Journal Articles

Intensity and Duration of Anticoagulation in Non-Cirrhotic, Non-Malignant Portal Vein Thrombosis

Senthil Sukumar, MD, Yu-Min Shen, MD

Blood (2018) 132 (Supplement 1): 2534.

https://doi.org/10.1182/blood-2018-99-114221

Published: 2018

Journal Articles

Risk of Subsequent Thrombosis in Patients with Isolated Heparin-Induced Thrombocytopenia

Heather R Wolfe, MD, Yu-Min Shen, MD

Blood (2018) 132 (Supplement 1): 3566.

https://doi.org/10.1182/blood-2018-99-117629

Published: 2018

Journal Articles

Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing "Empty Viral Particles" on Safety and Efficacy of Gene Transfer

Amit C Nathwani, MD PhD, Ulrike Reiss, MD, Edward Tuddenham, MD, Pratima Chowdary, MD, Jenny McIntosh, PhD, Anne Riddell, Jun Pie, Johnny N Mahlangu, MD, Michael Recht, MD PhD, Yu-Min Shen, MD, Kathleen G. Halka, MD, Michael M Meagher, PhD, Arthur W. Nienhuis, MD, Andrew M. Davidoff, MD, Sarah Mangles, Chris L Morton, Zhou Junfang, Vlad Calin Radulescu, MD

Blood (2018) 132 (Supplement 1): 491.

https://doi.org/10.1182/blood-2018-99-118334

Published: 2018

Journal Articles

Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium

Anastasia Sacharidou, Ken L. Chambliss, Victoria Ulrich, Jane E. Salmon, Yu-Min Shen, Joachim Herz, David Y. Hui, Lance S. Terada, Philip W. Shaul, Chieko Mineo

Blood (2018) 131 (19): 2097–2110.

https://doi.org/10.1182/blood-2017-11-814681

Published: 2018

Includes: Multimedia, Supplemental data

Journal Articles

Alternating Activated Prothrombin Complex Concentrate and Recombinant Activated Factor VII in the Successful Treatment of Patients with Acquired Hemophilia Α

Chakri Gavva, MD, Sandra L. Hofmann, MD PhD, Siayareh Rambally, MD, Yu-Min Shen, MD, Nicole De Simone, MDMPH, Ravi Sarode, MD

Blood (2016) 128 (22): 4967.

https://doi.org/10.1182/blood.V128.22.4967.4967

Published: 2016

Journal Articles

The Role of Whole Blood Platelet Aggregation Studies in the Diagnosis of Unexplained Bleeding Tendencies

Nicole De Simone, MDMPH, Ravi Sarode, MD, Sean Yates, MD, Karen Matevosyan, MD, Manasa Reddy, MD, Chakri Gavva, MD, Ayesha Zia, MD, Yu-Min Shen, MD

Blood (2015) 126 (23): 2260.

https://doi.org/10.1182/blood.V126.23.2260.2260

Published: 2015

Journal Articles

Analysis of Ordering Practice of Thrombophilia Testing at a Single Large Teaching Hospital

Judy Peih-Ying Tsai, MD, Evelyn O. Taiwo, MD, Natalie Cervantes, Guadalupe Jasso, Eugene P. Frenkel, MD, Ravindra Sarode, MD, Yu-Min Shen, MD

Blood (2010) 116 (21): 3188.

https://doi.org/10.1182/blood.V116.21.3188.3188

Published: 2010

Journal Articles

Incidence of Isolated Heparin-Induced Thrombocytopenia and the Risk of Developing Subsequent Thrombosis Using the New IgG Specific Anti-PF4/Heparin ELISA

Sofyan M. Radaideh, MD, Eugene P. Frenkel, MD, Ravindra Sarode, MD, Yu-Min Shen, MD

Blood (2010) 116 (21): 1448.

https://doi.org/10.1182/blood.V116.21.1448.1448

Published: 2010

Journal Articles

Low Risk 4T Score Can Rule out Heparin-Induced Thrombocytopenia.

Prapti A. Patel, MD, Catherine Burke, Karen Matevosyan, MD, Eugene P. Frenkel, MD, Ravindra Sarode, MD, Yu-Min Shen, MD

Blood (2009) 114 (22): 1328.

https://doi.org/10.1182/blood.V114.22.1328.1328

Published: 2009

Journal Articles

Optical Density of 1.0 Is a Better Cutoff for Positive HIT Ab ELISA.

Mohammad Ziari, MD, Catherine Burke, Karen Matevosyan, MD, Eugene P. Frenkel, MD, Ravindra Sarode, MD, Yu-Min Shen, MD

Blood (2009) 114 (22): 3515.

https://doi.org/10.1182/blood.V114.22.3515.3515

Published: 2009

Journal Articles

The Prevalence and Clinical Significance of IgA Antiphospholipid Antibodies (aPL).

Yu-Min Shen, MD, Anna Dyszkiewicz-Korpanty, MD, Ray Lee, MD, Jyoti Balani, MD, Eugene Frenkel, MD, Ravindra Sarode, MD

Blood (2005) 106 (11): 2647.

https://doi.org/10.1182/blood.V106.11.2647.2647

Published: 2005

NARROW

The Role of Emicizumab in Patients with Acquired Hemophilia A

Experiences with Emicizumab: A Retrospective Review of Patients on Emicizumab Therapy at the North Texas Hemophilia Treatment Center

Stable Therapeutic Transgenic FIX Levels for More Than 10 Years in Subjects with Severe Hemophilia B Who Received scAAV2/8-LP1-Hfixco Adeno-Associated Virus Gene Therapy

Bortezomib in Relapsed/Refractory Autoimmune-Mediated Thrombotic Thrombocytopenic Purpura: A Single-Center Case Series and Systematic Review

Surveillance of Monoclonal Gammopathy of Undetermined Significance: A Proposed Change

Intensity and Duration of Anticoagulation in Non-Cirrhotic, Non-Malignant Portal Vein Thrombosis

Risk of Subsequent Thrombosis in Patients with Isolated Heparin-Induced Thrombocytopenia

Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing "Empty Viral Particles" on Safety and Efficacy of Gene Transfer

Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium

Alternating Activated Prothrombin Complex Concentrate and Recombinant Activated Factor VII in the Successful Treatment of Patients with Acquired Hemophilia Α

The Role of Whole Blood Platelet Aggregation Studies in the Diagnosis of Unexplained Bleeding Tendencies

Analysis of Ordering Practice of Thrombophilia Testing at a Single Large Teaching Hospital

Incidence of Isolated Heparin-Induced Thrombocytopenia and the Risk of Developing Subsequent Thrombosis Using the New IgG Specific Anti-PF4/Heparin ELISA

Low Risk 4T Score Can Rule out Heparin-Induced Thrombocytopenia.

Optical Density of 1.0 Is a Better Cutoff for Positive HIT Ab ELISA.

The Prevalence and Clinical Significance of IgA Antiphospholipid Antibodies (aPL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only